CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Résumé de cet Article
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aye, T.
Right arrow Articles by Milne, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aye, T.
Right arrow Articles by Milne, B.
Canadian Journal of Anesthesia 49:283-286 (2002)
© Canadian Anesthesiologists' Society, 2002

Cardiothoracic Anesthesia, Respiration and Airway

Ketamine anesthesia for pericardial window in a patient with pericardial tamponade and severe COPD

[La kétamine utilisée pour l'anesthésie d'une ponction péricardique chez une patiente qui présente une tamponnade et une MPOC sévère]

Tim Aye, MD CCFP FRCP and Brian Milne, MD MSc FRCP

From the Department of Anesthesiology, Queen's University, Kingston, Ontario, Canada.

Dr. Brian Milne, Department of Anesthesiology, Kingston General Hospital, 76 Stuart Street, Kingston, Ontario K7L 2V7, Canada. Phone: 613-548-7827; Fax: 613-548-1375; E-mail: milneb{at}post.queensu.ca


    Abstract
 TOP
 Abstract
 Introduction
 Case report
 Discussion
 References
 
Purpose: To describe the use and concerns of ketamine anesthesia for pericardial window in a patient with pericardial tamponade and severe chronic obstructive pulmonary disease (COPD) with CO2 retention.

Clinical features: A 73-yr-old woman with long-standing COPD and cor pulmonale admitted with pericardial effusion and tamponade had surgery for a pericardial window receiving a total of ketamine 450 mg iv. Arterial pCO2 increased from 71.8 mmHg preoperatively to 96 mmHg intraoperatively postdrainage of 1000 mL of effusion. Hemodynamic stability and SpO2 >93% were maintained. Intubation was avoided and concerns of increased pulmonary vascular resistance and potential for right ventricular failure in an already compromised right ventricle were not observed clinically.

Conclusion: In this patient with pericardial tamponade, COPD and CO2 retention, the advantages of ketamine included maintaining spontaneous ventilation, avoiding institution and weaning of mechanical ventilation, bronchodilation and relative preservation of the CO2 response curve. Deleterious effects on right ventricular afterload were not observed.


    Introduction
 TOP
 Abstract
 Introduction
 Case report
 Discussion
 References
 
ANESTHESIA for pericardial window surgery in patients with pericardial tamponade can prove a challenge due to impaired diastolic filling and decreased stroke volume.1 Infiltration with local anesthesia, with or without sedation, and general anesthesia have been used for pericardiotomy in this situation.2 Ketamine, because it increases systemic vascular resistance and heart rate, and maintains cardiac contractility, is useful in patients with cardiac tamponade. Kaplan et al. reported on the use of ketamine to supplement local anesthesia for reopening a sternotomy in a postoperative cardiac tamponade patient with subsequent endotracheal anesthesia.3 There is, however, a paucity of information on the use of ketamine in patients with cardiac tamponade. Despite the fact that clinicians will often choose ketamine for patients with pericardial tamponade for its beneficial effects on maintaining systemic blood pressure, it can however have deleterious effects on right ventricular afterload. We describe a case of a patient with cor pulmonale and chronic obstructive pulmonary disease (COPD) who had a pericardial window under ketamine anesthesia where this was taken into consideration.


    Case report
 TOP
 Abstract
 Introduction
 Case report
 Discussion
 References
 
A 73-yr-old, 72-kg woman with long-standing COPD and cor pulmonale was admitted with pericardial effusion and tamponade. Admission one month prior for drainage of a pericardial effusion was complicated by insertion of a pulmonary artery catheter introducer into the carotid artery and postpericardiocentesis intrapericardial hemorrhage. Her pulmonary artery pressure at that time was 54/25 mmHg. She was discharged home on nasal O2 4 L•min–1. Prior to the present admission she experienced increasing dyspnea, orthopnea and peripheral edema. Other medical problems were obesity, stable angina, and hypothyroidism. Medications included enalapril, furosemide, isosorbide dinitrate, ranitidine, thyroxin, salbutamol and ipratropium bromide. She reported allergies to penicillin, codeine and morphine. Blood pressure on admission was 130/80 mmHg, heart rate 90 beats•min–1, respiratory rate 24 breaths•min–1 and a pulsus paradoxus of 10 mmHg. Breath sounds were decreased bilaterally with bibasilar crackles. Her SpO2 was 98% on nasal O2 4 L•min–1, and jugular venous pressure (JVP) was 3 cm H2O.

The following day she was in distress with increasing shortness of breath. She was unable to lie down stating she had never been this bad before. There had been no improvement with salbutamol inhalation and she had been started on prednisone. Her blood pressure was 116/68 mmHg, heart rate 110 beats•min–1, pulsus paradoxus 26 mmHg and SpO2 93% on nasal O2 4 L•min–1. Examination revealed decreased air entry with faint wheezes, JVP 8 cm H2O, with poorly palpable peripheral pulses. The patient refused to have another pericardiocentesis "awake" because of her previous experience and requested surgical drainage be performed under a general anesthetic.

Initially a thoracoscopic pericardial window was considered but in consultation with the attending anesthesiologist it was decided that problems with collapsing the emphysematous lung, difficulty in tolerating one lung anesthesia, and lack of an expeditious resolution made a subxiphoid approach to the pericardial window preferable. Anemia was corrected with two units of packed cells bringing the hemoglobin concentration to 106 mg•dL–1. Electrolytes and liver function tests were normal, an arterial blood gas on 4 L•min–1 nasal O2 showed pH 7.38, PO2 78.9 mmHg, PCO2 71.8 mmHg, HCO3 37.5 mmoL•L–1. Her electrocardiogram showed a sinus tachycardia with low voltage and her chest x-ray suggested a large pericardial effusion.

The patient eventually consented to needle drainage of the pericardial effusion prior to definitive surgery providing she was not aware. An echocardiogram demonstrated a very large anterior and posterior pericardial effusion and a chronically dilated right ventricle with systolic and diastolic collapse. Under echo guidance, in the intensive care unit (ICU) in the sitting position, 400 mL of chocolate coloured pericardial fluid was drained. Three boluses of midazolam 0.5 mg and propofol 20 mg iv were given during the procedure. Hemodynamics remained stable throughout the procedure and at the termination, right ventricular collapse was still present on echocardiogram. In the operating room with continuous intra-arterial monitoring, automated segment lead I, II, and V analysis, nasal O2 4 L•min–1, the patient was prepped and draped in the sitting position. After administration of glycopyrrolate 0.3 mg, and midazolam 1 mg, anesthesia was induced with ketamine in 25 mg increments to a total of 100 mg. Blood pressure was 120 mmHg systolic, and heart rate 100 beats•min–1. The patient was gradually returned to the supine position and lidocaine 1% was infiltrated locally. Subxiphoid drainage of 1000 mL of effusion increased her blood pressure to 140 mmHg systolic. Heart rate was 100–115 beats•min–1 and SpO2 >93% throughout. An intraoperative blood gas postdrainage showed a pH 7.28, PO2 102 mmHg, pCO2 96 mmHg, HCO3 44 mmoL•L–1. A total of 450 mg of ketamine were used during the procedure. The xiphisternum and a large ellipse of anterior pericardium were excised along with talc poudrage of the pericardial space. She returned to the ICU with stable hemodyamics and had no recall of events. There were no postoperative problems except for a pneumothorax, which required insertion of a left-sided chest tube, probably due to the pericardiocentesis. She was discharged home five days postoperatively and analysis of the pericardial fluid was negative for malignancy, showing only inflammatory cells.


    Discussion
 TOP
 Abstract
 Introduction
 Case report
 Discussion
 References
 
Pericardial tamponade is primarily a problem of impaired diastolic filling due to continuous elevation of intrapericardial pressure decreasing stroke volume, cardiac output and systemic blood pressure.1 The choice of anesthetic in this patient had to take into account the combined pathophysiology of pericardial tamponade and chronic obstructive lung disease with CO2 retention. Hypercarbia may increase right ventricular afterload, and cause dysrhythmias which could be detrimental to the failing right ventricle.2 While the use of ketamine has been deemed as potentially disastrous in patients with cardiac tamponade and minimal right ventricular functional reserve,4 Kaplan reported the use of ketamine 0.5 mg•kg–1 to supplement local anesthesia for opening the lower end of a sternotomy incision in a patient with postoperative tamponade. Following this, in contrast to our case, general anesthesia was induced with ketamine and succinylcholine, the trachea intubated and anesthesia maintained with nitrous oxide, pancuronium, and morphine.3 The sole use of local anesthesia advocated by Stanley et al.2 or awake intubation5 was not an option due to our patient's desire to be "asleep".

Although ketamine can have myocardial depressant effects in vitro and in patients who are maximally stressed with depleted catecholamines,6 in this case ketamine produced no decrease in blood pressure. The patient refused to be monitored with a pulmonary artery catheter due to her previous experience of an introducer having been placed into the carotid artery. This prevented monitoring of cardiac output and pulmonary artery pressures. The effect of ketamine on the pulmonary vasculature was a main consideration due to COPD with associated loss of pulmonary capillaries and arterial hypoxia leading to pulmonary vasoconstriction. Spotoft et al. found increases in pulmonary artery pressures mainly through increases in pulmonary vascular resistance unrelated to changes in PaO2 and PaCO2 with ketamine.4 There was initial concern that this increase in pulmonary vascular resistance may be greater than the increase in systemic vascular resistance which could cause an increase in shunt fraction. However, Rees et al. found no increase in shunt fraction using ketamine in humans during one lung anesthesia when compared to enflurane.7 One of the main problems with studies on the effects of ketamine on the pulmonary vasculature is controlling for the effects of respiratory depression on partial airway obstruction. Balfors et al. found no change in pulmonary vascular resistance during ketamine anesthesia in adults with assisted ventilation.8 Despite the effects of ketamine on pulmonary vasculature, its beneficial bronchodilating effect which parallels that of inhalational agents has been used in the treatment of reactive airways.9 In our patient with COPD, ketamine's bronchodilating effects may also have been advantageous.

Increases in PaCO2 were seen intraoperatively and this may have been due to the change of position from sitting to supine, diaphragmatic dysfunction from an upper abdominal incision, as well as the respiratory depressant effects of midazolam and ketamine. Surgical anesthesia and spontaneous ventilation can be achieved in numerous ways, but the majority are associated with direct myocardial depressant effects and decreases in systemic vascular resistance. Inhalational agents shift the CO2 response curve to the right and the associated hypercarbia may be detrimental to the patient with COPD and CO2 retention. Acute or chronic respiratory acidosis may cause central nervous side effects, increase right ventricular afterload, and cause dysrhythmias, all complications which should be avoided in patients with limited myocardial reserve. Although ketamine is a respiratory depressant, its' effects are mild10,11 and even though there is no guarantee against pulmonary aspiration, respiration is maintained with relatively intact laryngeal reflexes. In humans, ketamine alone causes mild respiratory depression similar but at a lesser degree to that seen with narcotics in the premedicant or analgesic dose range in that the slope of the ventilatory response to CO2 is unchanged, while the response curve is shifted to the right.12 Maintaining spontaneous ventilation may be better tolerated in the patient with cardiac tamponade.13 Increased tracheobronchial secretions may be attenuated with an antisialogogue and apneic spells may be minimized by titrating doses with slow injections.

Thus, in this patient with pericardial tamponade, COPD and CO2 retention, the advantages of ketamine included maintaining spontaneous ventilation, avoiding institution and weaning of mechanical ventilation, bronchodilation and relative preservation of the CO2 response curve, lack of cardiac depression, intense somatic analgesia, and amnesia. These advantages were felt to outweigh the disadvantages of effects on pulmonary vasculature, increased tracheobronchial secretions, and emergence reactions. The theoretical concerns of increased pulmonary vascular resistance and potential for right ventricular failure in an already compromised right ventricle were not observed clinically, and we were able to avoid intubation and mechanical ventilation in our patient with COPD and CO2 retention.

Revision received December 12, 2001. Accepted for publication October 31, 2001.


    References
 TOP
 Abstract
 Introduction
 Case report
 Discussion
 References
 
1 Lake CL. Anesthesia and pericardial disease. Anesth Analg 1983; 62: 431–43.[Free Full Text]

2 Stanley TH, Weidauer HE. Anesthesia for the patient with cardiac tamponade. Anesth Analg 1973; 52: 110–3.[Free Full Text]

3 Kaplan JA, Bland JW Jr, Dunbar RW. The perioperative management of pericardial tamponade. South Med J 1976; 69: 417–9.[Medline]

4 Spotoft H, Korshin JD, Sørensen MB, Skovsted P. The cardiovascular effects of ketamine used for induction of anaesthesia in patients with valvular heart disease. Can Anaesth Soc J 1979; 26: 463–7.[Medline]

5 Breen PH, MacVay MA. Pericardial tamponade: a case for awake endotracheal intubation (Letter). Anesth Analg 1996; 83: 658.

6 Stoelting R. Nonbarbiturate induction drugs. In: Stoelting R (Ed.). Pharmacology & Physiology in Anesthetic Practice, 3rd ed., Philadelphia, Pennsylvania: Lippincott-Raven, 1999: 140–57.

7 Rees DI, Gaines III GY. One-lung anesthesia–a comparison of pulmonary gas exchange during anesthesia with ketamine or enflurane. Anesth Analg 1984; 63: 521–5.[Abstract/Free Full Text]

8 Bålfors E, Häggmark S, Nyhman H, Rydvall A, Reiz S. Droperidol inhibits the effects of intravenous ketamine on central hemodynamics and myocardial oxygen consumption in patients with generalized atherosclerotic disease. Anesth Analg 1983; 62: 193–7.[Abstract/Free Full Text]

9 Sarma VJ. Use of ketamine in acute severe asthma. Acta Anaesthesiol Scand 1992; 36: 106–7.[Medline]

10 Soliman MG, Brindle GF, Kuster G. Response to hypercapnia under ketamine anaesthesia. Can Anaesth Soc J 1975; 22: 486–94.[Medline]

11 Reich DL, Silvay G. Ketamine: an update on the first twenty-five years of clinical experience. Can J Anaesth 1989; 36: 186–97.[Abstract/Free Full Text]

12 Bourke DL, Malit LA, Smith TC. Respiratory interactions of ketamine and morphine. Anesthesiology 1987; 66: 153–6.[Medline]

13 Möller CT, Schoonbee CG, Rosendorff C. Haemodynamics of cardiac tamponade during various modes of ventilation. Br J Anaesth 1979; 51: 409–14.[Abstract/Free Full Text]




This article has been cited by other articles:


Home page
Anesth. Analg.Home page
G. D. Williams, B. M. Philip, L. F. Chu, M. G. Boltz, K. Kamra, H. Terwey, G. B. Hammer, S. B. Perry, J. A. Feinstein, and C. Ramamoorthy
Ketamine Does Not Increase Pulmonary Vascular Resistance in Children with Pulmonary Hypertension Undergoing Sevoflurane Anesthesia and Spontaneous Ventilation
Anesth. Analg., December 1, 2007; 105(6): 1578 - 1584.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Résumé de cet Article
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aye, T.
Right arrow Articles by Milne, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aye, T.
Right arrow Articles by Milne, B.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS